Literature DB >> 6282262

Fluid-phase interaction of C1 inhibitor (C1 Inh) and the subcomponents C1r and C1s of the first component of complement, C1.

S Chesne, C L Villiers, G J Arlaud, M B Lacroix, M G Colomb.   

Abstract

Interactions between proenzymic or activated complement subcomponents of C1 and C1 Inh (C1 inhibitor) were analysed by sucrose-density-gradient ultracentrifugation and sodium dodecyl sulphate/polyacrylamide-gel electrophoresis. The interaction of C1 Inh with dimeric C1r in the presence of EDTA resulted into two bimolecular complexes accounting for a disruption of C1r. The interaction of C1 Inh with the Ca2+-dependent C1r2-C1s2 complex (8.8 S) led to an 8.5 S inhibited C1r-C1s-C1 Inh complex (1:1:2), indicating a disruption of C1r2 and of C1s2 on C1 Inh binding. The 8.5 S inhibited complex was stable in the presence of EDTA; it was also formed from a mixture of C1r, C1s and C1 Inh in the presence of EDTA or from bimolecular complexes of C1r-C1 Inh and C1s-C1 Inh. C1r II, a modified C1r molecule, deprived of a Ca2+-binding site after autoproteolysis, did not lead to an inhibited tetrameric complex on incubation with C1s and C1 Inh. These findings suggest that, when C1 Inh binds to C1r2-C1s2 complex, the intermonomer links inside C1r2 or C1s2 are weakened, whereas the non-covalent Ca2+-independent interaction between C1r2 and C1s2 is strengthened. The nature of the proteinase-C1 Inh link was investigated. Hydroxylamine (1M) was able to dissociate the complexes partially (pH 7.5) or totally (pH 9.0) when the incubation was performed in denaturing conditions. An ester link between a serine residue at the active site of C1r or C1s and C1 Inh is postulated.

Entities:  

Mesh:

Substances:

Year:  1982        PMID: 6282262      PMCID: PMC1163609          DOI: 10.1042/bj2010061

Source DB:  PubMed          Journal:  Biochem J        ISSN: 0264-6021            Impact factor:   3.857


  28 in total

1.  C1 inactivator.

Authors:  P C Harpel
Journal:  Methods Enzymol       Date:  1976       Impact factor: 1.600

2.  A simplified procedure for the purification of C1-inactivator from human plasma. Interaction with complement subcomponents C1r and C1s.

Authors:  A Reboul; G J Arlaud; R B Sim; M G Colomb
Journal:  FEBS Lett       Date:  1977-07-01       Impact factor: 4.124

3.  Electrophoretic analysis of the major polypeptides of the human erythrocyte membrane.

Authors:  G Fairbanks; T L Steck; D F Wallach
Journal:  Biochemistry       Date:  1971-06-22       Impact factor: 3.162

4.  Isolation and characterization of the proenzyme form of the C1r subunit of the first complement component.

Authors:  G Valet; N R Cooper
Journal:  J Immunol       Date:  1974-05       Impact factor: 5.422

5.  Nature of the active site of a subunit of the first component of human complement.

Authors:  D H Bing
Journal:  Biochemistry       Date:  1969-11       Impact factor: 3.162

6.  The reliability of molecular weight determinations by dodecyl sulfate-polyacrylamide gel electrophoresis.

Authors:  K Weber; M Osborn
Journal:  J Biol Chem       Date:  1969-08-25       Impact factor: 5.157

7.  Physicochemical and functional characterization of the C1r subunit of the first complement component.

Authors:  R J Ziccardi; N R Cooper
Journal:  J Immunol       Date:  1976-02       Impact factor: 5.422

8.  Isolation and characterization of the proenzyme form of the C1s subunit of the first complement component.

Authors:  G Valet; N R Cooper
Journal:  J Immunol       Date:  1974-01       Impact factor: 5.422

9.  The structure and enzymic activities of the C1r and C1s subcomponents of C1, the first component of human serum complement.

Authors:  R B Sim; R R Porter; K B Reid; I Gigli
Journal:  Biochem J       Date:  1977-05-01       Impact factor: 3.857

10.  Evidence for the formation of an ester between thrombin and heparin cofactor.

Authors:  W G Owen
Journal:  Biochim Biophys Acta       Date:  1975-10-20
View more
  12 in total

1.  Complement component C1q enhances invasion of human mononuclear phagocytes and fibroblasts by Trypanosoma cruzi trypomastigotes.

Authors:  M T Rimoldi; A J Tenner; D A Bobak; K A Joiner
Journal:  J Clin Invest       Date:  1989-12       Impact factor: 14.808

2.  Deep Intronic Mutation in SERPING1 Caused Hereditary Angioedema Through Pseudoexon Activation.

Authors:  Pavla Hujová; Přemysl Souček; Lucie Grodecká; Hana Grombiříková; Barbora Ravčuková; Pavel Kuklínek; Roman Hakl; Jiří Litzman; Tomáš Freiberger
Journal:  J Clin Immunol       Date:  2020-01-25       Impact factor: 8.317

3.  C1 inhibitor removes the entire C1qr2s2 complex from anti-C1Q monoclonal antibodies with low binding affinities.

Authors:  C H Chen; C F Lam; R J Boackle
Journal:  Immunology       Date:  1998-12       Impact factor: 7.397

4.  Molecular modelling of human complement subcomponent C1q and its complex with C1r2C1s2 derived from neutron-scattering curves and hydrodynamic properties.

Authors:  S J Perkins
Journal:  Biochem J       Date:  1985-05-15       Impact factor: 3.857

5.  Demonstration of modified inactive first component of complement (C1) inhibitor in the plasmas of C1 inhibitor-deficient patients.

Authors:  B L Zuraw; J G Curd
Journal:  J Clin Invest       Date:  1986-08       Impact factor: 14.808

Review 6.  Aspects of C1-inhibitor biochemistry and pathophysiology.

Authors:  T K Nilsson
Journal:  Clin Rheumatol       Date:  1987-09       Impact factor: 2.980

7.  Structural features of the first component of human complement, C1, as revealed by surface iodination.

Authors:  C L Villiers; S Chesne; M B Lacroix; G J Arlaud; M G Colomb
Journal:  Biochem J       Date:  1982-04-01       Impact factor: 3.857

8.  C1 inactivator-C1s complexes in inflammatory joint disease.

Authors:  R D Inman; P C Harpel
Journal:  Clin Exp Immunol       Date:  1983-09       Impact factor: 4.330

9.  Structural and circular-dichroism studies on the interaction between human C1-esterase inhibitor and C1s.

Authors:  T Nilsson; I Sjöholm; B Wiman
Journal:  Biochem J       Date:  1983-09-01       Impact factor: 3.857

Review 10.  The first component of human complement (C1): activation and control.

Authors:  R J Ziccardi
Journal:  Springer Semin Immunopathol       Date:  1983
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.